Skip to main content
Clinical Trials/DRKS00010246
DRKS00010246
Not yet recruiting
未知

Anterior cruciate ligament reconstruction with autologous semitendinosus- or quadriceps tendon graft: Are there differences in objective and subjective patients' outcome? A randomized controlled trial. - QuadSemiT

niversitätsklinikum Münster0 sites60 target enrollmentApril 11, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Rupture
Sponsor
niversitätsklinikum Münster
Enrollment
60
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2016
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Münster

Eligibility Criteria

Inclusion Criteria

  • Primary rupture of anterior cruciate ligament (for randomization)
  • \- for the accessory controll group (study arm No 3, ACL Revision with Quadriceps tendon graft) a rerupture after primary ACL reconstruction/suture is inclusion criterion
  • \- Age 16\-60 years
  • \- Signed informed consent, study and privacy agreements
  • \- Succesfully completed all standard preoperative procedures especially from anaesthesological und surgical point of view
  • \- Willing to participate on follow\-up examinations.
  • \- Minor concomitant injuries such as small meniscus lesions (\<1/3 partial meniscectomy or minor sutures), I\-II° MCL instability, bone bruise without relevant chondral lesions or hemarthros are acceptable for inclusion.

Exclusion Criteria

  • \- No compliance
  • \- Denial of participating in rehabilitation program
  • \- Severe traumatic or degenerative chondral or meniscal injuries
  • \- Multiligamental injuries/instability of higher grades (LCL, PCL or III° MCL)
  • \- Prior donation/extraction of tendon grafts at the same leg (except for the study arm No 3 / ACL Revision group if quadriceps tendon is still available)
  • \- Relevant co\-medication or co\-morbidities
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials